Results 131 to 140 of about 22,928 (253)

Dental implants in oral rehabilitation after denosumab and bisphosphonate-related osteonecrosis of the jaw in a young patient: an unusual case

Journal of Oral Medicine and Oral Surgery
Patients often request oral rehabilitation after surgical resection. Here, a 19-year-old patient developed medication-related osteonecrosis of the jaw after treatment with antiresorptive therapy.
Salabert Noémie, Loison-Robert Ludwig, Ahossi Victorin, Hoarau David   +3 more
doaj   +1 more source

Successful radiofrequency thermocoagulation of the mandibular nerve for intractable pain associated with medication-related osteonecrosis of the jaw: a case report

JA Clinical Reports
Background Bisphosphonates may cause serious adverse events, including osteonecrosis of the jaw. This article describes a case of successful application of radiofrequency thermocoagulation for pain caused by osteonecrosis of the jaw. Case presentation An
Sho Shinotsuka, Aiko Maeda, Tomoka Eri, Nozomi Kameyama, Chiaki Yamada, Masako Asada, Ken Yamaura   +6 more
doaj   +1 more source

Bilateral Orocutaneous Fistulas and Mandibular Osteonecrosis

International Journal of Dermatology, Volume 65, Issue 2, Page 374-375, February 2026.
Krisztian Nemeth, Mollye Goldberg, Zachary Fridirici   +2 more
wiley   +1 more source

Osteonekroza čeljusti udružena s bisfosfonatima – tri prikaza slučaja i pregled literature [PDF]

, 2011
A severe complication of the administration of bisphosphonate-containing medications is known as bisphosphonate-associated osteonecrosis of the jaws (BONJ). A case series of three patients affected by BONJ is presented. These patients currently represent
Anastasia Zheleva, Angel Bakardjiev, Boyan Vladimirov, Elena Poriazova, Georgi Hadjigeorgiev, Petia Pechalova, Stefan Goranov, Vesselina Goranova-Marinova, Zaprian Zaprianov   +8 more
core   +1 more source

Osteopathology induced by bisphosphonates and dental implants: clinical observations [PDF]

, 2018
Objectives: Although there are many reports about risk factors for the development of BP-associated osteonecrosis of the jaws, the role of dental implants as a local risk factor is still discussed, especially in patients with oral BP treatment. Until now,
Grätz, Klaus-Wilhelm, Jacobsen, Christine, Metzler, Philipp, Obwegeser, Joachim, Rössle, Matthias, Zemann, Wolfgang   +5 more
core  

Erratum to: Osteonecrosis of the jaw (ONJ) in renal cell cancer patients after treatment including zoledronic acid or denosumab [PDF]

, 2014
Vittorio Fusco, Alberto Bedogni, Giuseppina Campisi   +2 more
openalex   +1 more source

Medication‐Related Osteonecrosis of the Jaw: A Case Report of an Unusual Side Effect of Adalimumab [PDF]

, 2023
Laura Sisalli, Francesco Giordano, Andrea Chiacchio, Alfonso Acerra, Mario Caggiano   +4 more
openalex   +1 more source

Case Report: Development of medication-related osteonecrosis of the jaw in a patient on long-term infliximab therapy

Frontiers in Oral Health
Medication-Related Osteonecrosis of the Jaw (MRONJ) is a challenging and evolving aspect of Oral and Maxillofacial Surgery. In recent years, several medications apart from those traditionally associated with MRONJ such as bisphosphates (BPs) and ...
Derek Oryniak, Meagan Brown, Lillie Cholakis, Reda Elgazzar   +3 more
doaj   +1 more source

Osteoquimionecrosis de los maxilares asociada a la administración de bifosfonatos por vía endovenosa: a propósito de seis casos [PDF]

, 2016
La osteonecrosis de los maxilares en pacientes con cáncer se asociaba, hasta ahora, con la radioterapia, aunque recientemente se han reportado numerosos casos de osteoquimionecrosis de los maxilares (OQNM) relacionada con la quimioterapia, y más ...
Berini Aytés, Leonardo, Gay Escoda, Cosme, Herrero Fonollosa, M., Masip Zurriaga, E.   +3 more
core  

Osteonecrosis of the Jaw and Bilateral Atypical Femoral Fracture Both Occurring During Treatment for Osteoporosis: A Case Report

Journal of the ASEAN Federation of Endocrine Societies, 2018
Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) are rare potential adverse effects of bisphosphonates and RANKL antibody therapy. The pathogenic mechanisms of both conditions are known to be independent of each other.
Edelissa Payumo, Beinjerinck Ivan Cudal, Thelma Crisostomo   +2 more
doaj